Choongwae to launch a new drug for anti-cholesterol markets.

Published: 2005-07-07 06:59:00

Updated: 2005-07-07 06:59:00

Choongwae launched Rivaro tablet, a new anti-cholesterol drug (Pitavastatin) on July 1, which was jointly developed by Japanese Kowa and Nissan Chemical having excellent efficacy and safety profiles.

According to the clinical studies conducted at Seoul National University and Shinchon Severanc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK